DB-1202

· DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-1202, covering 2023-03-31 to 2023-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DB-1202 Monotherapy in Advanced Solid Tumors [Phase 1, Phase 2]